Literature DB >> 19383277

Predicted phenotypes of dry eye: proposed consequences of its natural history.

Anthony J Bron1, Norihiko Yokoi, Eamonn Gafney, John M Tiffany.   

Abstract

This paper reviews current knowledge of the pathophysiology of dry eye and predicts that the clinical picture in late disease differs in both severity and quality from that in early disease. It is hypothesized that hybrid forms evolve, in which aqueous-deficient dry eye (ADDE) takes on features of evaporative dry eye (EDE) and vice versa. As a consequence, early and late forms may require different diagnostic criteria and respond to different therapeutic regimes. Tear hyperosmolarity plays a key role in the damage mechanism of dry eye, and ADDE is recognized to be a low-volume, hyperosmolar state. As ADDE advances, a progressive decrease in lacrimal secretion occurs, exacerbated by loss of the corneal reflex. This causes a decrease in tear volume, thinning of the aqueous tear film, and retarded spreading of the tear film lipid layer. The latter is hypothesized to cause an increase in evaporative water loss and an added evaporative component to the dry eye. Thus, in advanced disease, the hybrid state would be an organic ADDE, accompanied by a functional EDE in the absence of meibomian gland dysfunction. This functional EDE would respond to agents that expand the tear volume, restore corneal sensitivity, or provide an artificial tear film lipid layer.

Entities:  

Mesh:

Year:  2009        PMID: 19383277     DOI: 10.1016/s1542-0124(12)70299-9

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  42 in total

Review 1.  The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee.

Authors:  Alan Tomlinson; Anthony J Bron; Donald R Korb; Shiro Amano; Jerry R Paugh; E Ian Pearce; Richard Yee; Norihiko Yokoi; Reiko Arita; Murat Dogru
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 2.  The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD.

Authors:  Debra A Schaumberg; Jason J Nichols; Eric B Papas; Louis Tong; Miki Uchino; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 3.  TFOS DEWS II pain and sensation report.

Authors:  Carlos Belmonte; Jason J Nichols; Stephanie M Cox; James A Brock; Carolyn G Begley; David A Bereiter; Darlene A Dartt; Anat Galor; Pedram Hamrah; Jason J Ivanusic; Deborah S Jacobs; Nancy A McNamara; Mark I Rosenblatt; Fiona Stapleton; James S Wolffsohn
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

4.  Variability of Tear Osmolarity in Patients With Dry Eye.

Authors:  Vatinee Y Bunya; Nicole M Fuerst; Maxwell Pistilli; Bridgette E McCabe; Rebecca Salvo; Ilaria Macchi; Gui-Shuang Ying; Mina Massaro-Giordano
Journal:  JAMA Ophthalmol       Date:  2015-06       Impact factor: 7.389

5.  New testing options for diagnosing and grading dry eye disease.

Authors:  Gary N Foulks; Stephen C Pflugfelder
Journal:  Am J Ophthalmol       Date:  2014-03-12       Impact factor: 5.258

6.  High osmotic pressure increases reactive oxygen species generation in rabbit corneal epithelial cells by endoplasmic reticulum.

Authors:  Peng Wang; Minjie Sheng; Bing Li; Yaping Jiang; Yihui Chen
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

7.  Hyperosmolar Tears Induce Functional and Structural Alterations of Corneal Nerves: Electrophysiological and Anatomical Evidence Toward Neurotoxicity.

Authors:  Harumitsu Hirata; Kamila Mizerska; Carl F Marfurt; Mark I Rosenblatt
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

8.  Tear meniscus dimensions in tear dysfunction and their correlation with clinical parameters.

Authors:  Cynthia I Tung; Andrew F Perin; Koray Gumus; Stephen C Pflugfelder
Journal:  Am J Ophthalmol       Date:  2013-09-28       Impact factor: 5.258

9.  Hyperosmolar tears enhance cooling sensitivity of the corneal nerves in rats: possible neural basis for cold-induced dry eye pain.

Authors:  Harumitsu Hirata; Mark I Rosenblatt
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-19       Impact factor: 4.799

10.  Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells.

Authors:  Megan E Cavet; Karen L Harrington; Keith W Ward; Jin-Zhong Zhang
Journal:  Mol Vis       Date:  2010-09-02       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.